Li, Y.; Zhou, W.; Meng, X.; Murray, S.D.; Li, L.; Fronk, A.; Lazaro-Camp, V.J.; Wen, K.-k.; Wu, M.; Dupuy, A.;
et al. Utilizing an Endogenous Progesterone Receptor Reporter Gene for Drug Screening and Mechanistic Study in Endometrial Cancer. Cancers 2022, 14, 4883.
https://doi.org/10.3390/cancers14194883
AMA Style
Li Y, Zhou W, Meng X, Murray SD, Li L, Fronk A, Lazaro-Camp VJ, Wen K-k, Wu M, Dupuy A,
et al. Utilizing an Endogenous Progesterone Receptor Reporter Gene for Drug Screening and Mechanistic Study in Endometrial Cancer. Cancers. 2022; 14(19):4883.
https://doi.org/10.3390/cancers14194883
Chicago/Turabian Style
Li, Yiyang, Wei Zhou, Xiangbing Meng, Sarina D. Murray, Long Li, Abby Fronk, Vanessa J. Lazaro-Camp, Kuo-kuang Wen, Meng Wu, Adam Dupuy,
and et al. 2022. "Utilizing an Endogenous Progesterone Receptor Reporter Gene for Drug Screening and Mechanistic Study in Endometrial Cancer" Cancers 14, no. 19: 4883.
https://doi.org/10.3390/cancers14194883
APA Style
Li, Y., Zhou, W., Meng, X., Murray, S. D., Li, L., Fronk, A., Lazaro-Camp, V. J., Wen, K.-k., Wu, M., Dupuy, A., Leslie, K. K., & Yang, S.
(2022). Utilizing an Endogenous Progesterone Receptor Reporter Gene for Drug Screening and Mechanistic Study in Endometrial Cancer. Cancers, 14(19), 4883.
https://doi.org/10.3390/cancers14194883